Latest filing published 13 Nov 2017 for Apellis Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Michael E. Gellert: trading record in brief
Michael E. Gellert has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Seacor Holdings Inc /NEW/ and Apellis Pharmaceuticals, Inc. In total, 7 filings cover trades dated from 17 May 2006 to 13 November 2017.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 13 November 2017: a transaction, in Apellis Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael E. Gellert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 798,068 sharesCommon StockSEC:0000899243-17-026031:0
- 3,000 shares@ US$43.00Common StockSEC:0001209191-10-029316:0
- 500 shares0Common StockSEC:0000909518-09-000344:0
- 500 shares0Common StockSEC:0000909518-08-000500:0
- 500 shares0Common StockSEC:0000909518-07-000501:0
- 500 shares0Common StockSEC:0000909518-07-000499:0
- 500 sharesCommon StockSEC:0001104659-06-036426:0
7 of 7 declarations
